Text- and app-based primary care startup 98point6 has hauled in a $118 million Series E round led by the Growth Fund of L Catterton and Activant Capital. Goldman Sachs Merchant Banking Division and other unnamed investors also took part.
The company's on-demand primary care services for consumers and payers use artificial intelligence and a text-based interface to collect information about the...
Rx.Health, a Mount Sinai spinoff working on an app prescription platform for enterprises, has named Richard Strobridge as its new CEO.
He's perhaps best known within digital health as the cofounder and CEO of connected blood glucose monitoring-device company Entra Health, which was sold to CRF Health in 2016. After a few years there as VP of healthcare, Strobridge founded and helmed Nextbridge...
TestCard has announced its noninvasive at-home urinary tract infection test kit to be launched in the UK in August 2020.
With the accompanying mobile app, users can detect a UTI through immediate testing results and choose to share information with a healthcare professional.
To take the test, the first step is to scan the QR code with the TestCard app to inform it of the type of test being...
Pharma giant Novartis and O2 innovation arm Wayra UK revealed last week that Virtue, TestCard and ExSeed would join its nine-month Health Hub accelerator programme.
“After a rigorous judging day, I believe the innovations these three startups offer will make a significant difference to patients and the NHS,” said Novartis Market Access Director Fiona Bride. “I look forward to supporting them over...
What happened
TestCard, a London-based digital health company, has raised $1.7 million (£1.25 million) in seed funding from Neo Ventures, a small Bulgarian investment firm focused on accelerating European startups.
The company is entering the rapidly-maturing smartphone-enabled home urinalysis market, with plans to release its first product in the UK this year. The product is a physical postcard...
